Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Precision Health Database|Search|PHGKB

Last data update: May 31, 2023. (Total: 60044 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 361 Records)

Next

Query Trace:
Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome.
Po-Han Lin et al. J Gynecol Oncol 2023
Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer.
T M Reissig et al. ESMO Open 2023 8(3) 101539
Pancreatic Cancer Screening for At-risk Individuals (Pancreas Scan Study): Yield, Harms and Outcomes from a Prospective Multi-Center Study.
Ishani Shah et al. Am J Gastroenterol 2023
Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening?
Alexandra M Roch et al. J Surg Oncol
Familial aggregation of early-onset cancers in early-onset breast cancer families.
Jasmiina N J Rantala et al. Int J Cancer
Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area.
Valentina Zampiga et al. Cancers (Basel) 2023 15(7)
Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma.
Kum Hei Ryu et al. Cancer research and treatment 2023
The Landscape and Therapeutic Targeting of BRCA1, BRCA2 and Other DNA Damage Response Genes in Pancreatic Cancer.
Ioannis A Voutsadakis et al. Current issues in molecular biology 2023 45(3) 2105-2120
Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients with Pancreatic Cancer or Suspected Related Hereditary Syndromes: Historical Prospective Analysis.
Arianna Dal Buono et al. Cancers 2023 15(6)
Adherence to NCCN Genetic Testing Guidelines in Pancreatic Cancer and Impact on Treatment.
Fionnuala Crowley et al. The oncologist 2023
Assessment of a Peer Physician Coaching Partnership Between a Designated Cancer Center Genetics Service and a Community Cancer Network Hospital.
Lauren G Santos et al. JAMA network open 2023 6(3) e231723
Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study.
Hiroo Fujitani et al. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2023
Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunich Molecular Tumor Board.
Klara Dorman et al. Targeted oncology 2023
Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans.
Guettchina Telisnor et al. Journal of the National Medical Association 2023
Identification of individuals at high-risk for pancreatic cancer using a digital patient-input tool combining family cancer history screening and new-onset diabetes.
Derk C F Klatte et al. Preventive medicine reports 2023 31102110
The Michigan Genetic Hereditary Testing (MiGHT) study's innovative approaches to promote uptake of clinical genetic testing among cancer patients: a study protocol for a 3-arm randomized controlled trial.
Lynette Hammond Gerido et al. Trials 2023 24(1) 105
Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice.
Takuo Yamai et al. Cancers 2023 15(3)
Characteristics of familial pancreatic cancer families with additional colorectal carcinoma.
Bettina Lehman et al. Familial cancer 2023
Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study.
Francesca Tavano et al. Molecular medicine (Cambridge, Mass.) 2023 29(1) 14
FAMILIAL PANCREATIC CANCER.
Nero Lorenzo Del et al. Clinics and research in hepatology and gastroenterology 2023 102079
Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer
JH Stickler et al, NEJM, December 21, 2022
Pancreatic Cancer: Beyond Brca Mutations
V Ricci et al, J Per Med, December 16, 2022
Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening.
Badheeb Mohamed et al. Current oncology (Toronto, Ont.) 2022 29(11) 8693-8719
Association Between Family History and Risk of Pancreatic Cancer in Patients With BRCA1 and BRCA2 Pathogenic Variants.
Shah Ishani et al. Pancreas 2022 51(7) 733-738
Targeting KRAS in Pancreatic Cancer
D Cowser et al, J Per Med, November 8, 2022
Familial Pancreatic Cancer.
Saba Helena et al. Gastroenterology clinics of North America 2022 51(3) 561-575
Current Screening Strategies for Pancreatic Cancer.
Vanek Petr et al. Biomedicines 2022 10(9)
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients.
Puccini Alberto et al. Cancers 2022 14(18)
Treatment Patterns of Real-World Patients with TRK Fusion Cancer Treated by US Community Oncologists.
Klink Andrew J et al. Targeted oncology 2022
Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction
NA Fraunhoffer et al, NPJ Precision Oncology, August 17, 2022
TOP